US 9566329
Live, attenuated rubella vector to express vaccine antigens
granted A61KA61K2039/53A61K2039/54
Quick answer
US patent 9566329 (Live, attenuated rubella vector to express vaccine antigens) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K2039/53, A61K2039/54, A61K2039/545, A61K39/12